Casting light on multiple sclerosis heterogeneity.....
Posted: Mon Mar 18, 2013 2:39 am
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology
Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome.
Spinal cord pathology is common and contributes significantly to disability in the disease.
The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is unknown..... Read More - http://www.ms-uk.org/index.cfm/genetics
Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome.
Spinal cord pathology is common and contributes significantly to disability in the disease.
The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is unknown..... Read More - http://www.ms-uk.org/index.cfm/genetics